Search results
Found 11152 matches for
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
Nicky Iyer
Administration
Nicky Iyer - Executive Assistant to the Head of Department and Senior Executive Officer
Simon Knight
Academics
MA MChir FRCS Simon Knight - Associate Professor of Transplant Surgery and Senior Clinical Research Fellow
Alastair Lamb
Academics
MA(Oxon), MBChB, PhD(Cantab), FRCS(Urol) Alastair Lamb - Associate Professor
Kalina Bednarek
Research Support
Kalina Bednarek - Research Technician in Clinical Islet Isolation and Transplantation
Nithesh Ranasinha
Students & Academic Clinical Fellows
Nithesh Ranasinha - Academic Clinical Fellow in Urology
Regent Lee
Academics
MBBS, MS(Vasc Surg), DPhil (Oxon), FRCS (Vasc Surg) Regent Lee - Associate Professor of Vascular Surgery